Apg-1387 (smac mimetic) Uses, Dosage, Side Effects and more
Apg-1387 (smac mimetic) is under investigation in clinical trial NCT04568265 (A Clinical Study of Apg-1387 (smac mimetic) in Combination With Entecavir in Patients With Chronic Hepatitis B).
| Trade Name | Apg-1387 (smac mimetic) |
| Generic | APG-1387 |
| APG-1387 Other Names | Apg-1387 (smac mimetic) |
| Type | |
| Formula | C60H72N10O10S2 |
| Weight | Average: 1157.42 Monoisotopic: 1156.487430906 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
